Highlander Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History

Highlander Capital Management, LLC

$245 Million
Q1 2024

A detailed history of Highlander Capital Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Highlander Capital Management, LLC holds 72,100 shares of TEVA stock, worth $1.29 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

72,100

Previous 62,850 14.72%

Holding current value

$1.29 Million

Previous $656,000 55.03%

% of portfolio

0.42%

Previous 0.28%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$10.67 - $14.43 $98,697 - $133,477	9,250 Added 14.72%	72,100 $1.02 Million
Q4 2023 Jan 24, 2024	SELL	$8.12 - $10.63 $4,059 - $5,315	-500 Reduced 0.79%	62,850 $656,000
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $67,320 - $96,300	9,000 Added 16.56%	63,350 $646,000
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $2,160 - $2,841	-300 Reduced 0.55%	54,350 $409,000
Q4 2022 Feb 15, 2023	SELL	$7.95 - $9.48 $16,695 - $19,908	-2,100 Reduced 3.7%	54,650 $498,000
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $19,208 - $33,460	2,800 Added 5.19%	56,750 $458,000
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $3,985 - $5,616	-540 Reduced 0.99%	53,950 $406,000
Q1 2022 May 09, 2022	SELL	$7.33 - $9.39 $7,330 - $9,390	-1,000 Reduced 1.8%	54,490 $512,000
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $1,580 - $2,038	-200 Reduced 0.36%	55,490 $444,000
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $7,542 - $9,162	-900 Reduced 1.59%	55,690 $542,000
Q1 2021 May 14, 2021	BUY	$10.34 - $12.81 $349,492 - $432,978	33,800 Added 148.31%	56,590 $653,000
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $10,762 - $13,799	-1,250 Reduced 5.2%	22,790 $220,000
Q3 2020 Nov 17, 2020	SELL	$8.57 - $12.69 $12,855 - $19,035	-1,500 Reduced 5.87%	24,040 $217,000
Q1 2020 May 27, 2020	SELL	$6.69 - $13.45 $8,362 - $16,812	-1,250 Reduced 4.67%	25,540 $229,000
Q4 2019 Feb 13, 2020	SELL	$6.53 - $10.72 $53,546 - $87,904	-8,200 Reduced 23.44%	26,790 $263,000
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $27,720 - $43,200	-4,500 Reduced 11.4%	34,990 $241,000
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $24,765 - $47,946	3,050 Added 8.37%	39,490 $364,000
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $50,635 - $65,032	-3,250 Reduced 8.19%	36,440 $571,000
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $26,262 - $42,912	-1,800 Reduced 4.34%	39,690 $618,000
Q3 2018 Nov 09, 2018	SELL	$21.06 - $25.65 $492,803 - $600,210	-23,400 Reduced 36.06%	41,490 $894,000
Q2 2018 Aug 15, 2018	BUY	$16.77 - $24.71 $16,770 - $24,710	1,000 Added 1.57%	64,890 $1.58 Million
Q1 2018 May 16, 2018	SELL	$16.68 - $22.07 $68,388 - $90,487	-4,100 Reduced 6.03%	63,890 $1.08 Million
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $128,628 - $218,771	-11,454 Reduced 14.42%	67,990 $1.29 Million
Q3 2017 Nov 15, 2017	BUY	$15.41 - $32.17 $1.22 Million - $2.56 Million	79,444	79,444 $1.4 Million

Others Institutions Holding TEVA

# of Institutions

632

Shares Held

576M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.

Account

Highlander Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History